VRHI (Veri Medtech Holdings) Total Debt per Share: $0.00 (As of Dec. 2021)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VRHI Veri Medtech Holdings Inc VRHI
35 GF Score
Price $2.35
View Full Analysis

What is Veri Medtech Holdings Total Debt per Share?

Veri Medtech Holdings VRHI +17.32% 35 Total Debt per Share is $0.00 as of Dec. 2021. GuruFocus rates VRHI with a GF Score™ of 35/100.

$0.00 (As of Dec. 2021)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Veri Medtech Holdings's Total Debt Per Share for the quarter that ended in Dec. 2021 was $0.00.

Veri Medtech Holdings Total Debt per Share Historical Data

* Premium members only.

The historical data trend for Veri Medtech Holdings's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veri Medtech Holdings Total Debt per Share Chart

Veri Medtech Holdings Annual Data
Trend Dec21
Total Debt per Share
0.00

Veri Medtech Holdings Semi-Annual Data
Dec21
Total Debt per Share 0.00
VRHI
35GF Score
Veri Medtech Holdings Inc VRHI
Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veri Medtech Holdings Total Debt per Share Calculation

Veri Medtech Holdings's Total Debt Per Share for the fiscal year that ended in Dec. 2021 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(0.00+0.00)/0.00
=N/A

Veri Medtech Holdings's Total Debt Per Share for the quarter that ended in Dec. 2021 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(0.00+0.00)/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of $0.00 mean?
Veri Medtech Holdings (VRHI) has a Total Debt per Share of $0.00 as of Dec. 2021. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Veri Medtech Holdings and its competitors.
Is Veri Medtech Holdings' Total Debt per Share too high?
Veri Medtech Holdings' current Total Debt per Share is $0.00. Overall, Veri Medtech Holdings has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Veri Medtech Holdings' Total Debt per Share compare to MMVVF and BLMZ?
Veri Medtech Holdings' Total Debt per Share of $0.00 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Healthcare Providers & Services company?
A good Total Debt per Share depends on the Healthcare Providers & Services industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Veri Medtech Holdings and its competitors. Veri Medtech Holdings's current Total Debt per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veri Medtech Holdings stock overvalued right now?
Veri Medtech Holdings (VRHI) has a current Total Debt per Share of $0.00. The current Total Debt per Share is $0.00. Veri Medtech Holdings' overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For Veri Medtech Holdings (VRHI), the current Total Debt per Share is $0.00 as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Veri Medtech Holdings Business Description

Address 1660 International Drive, Suite 600, McClean, VA, USA, 22101
Veri Medtech Holdings Inc is a healthcare technology company that offers alternative medicine, personalized diagnostics, and wellness medication on demand. The company leverages telehealth infrastructure, diagnostic intelligence, and scalable digital systems to meet the growing demand for accessible, stigma-free healthcare. Strategically positioned for growth, Veri MedTech actively explores acquisitions that complement its core capabilities and enhance patient engagement across emerging sectors of alternative medicine, longevity, and wellness science. With an integration and operational efficiency track record, the company drives accelerated revenue through the continuous generation of high-value patient databases and recurring service models.
35GF Score

Get the complete analysis for VRHI

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.35
Price